Plan for obtaining human biological samples at non-U.S. clinical research sites for currently unspecified genetic analyses

This is a study to collect blood and saliva samples from former and current participants in…

A phase IIIb, randomized, open-label study of the safety and efficacy of Dolutegravir or Efavirenz each administered with two NRTIs in HIV-1-infected antiretroviral therapy-naïve adults starting treatment for Rifampicin-sensitive tuberculosis

This is a Phase III b, randomized, open-label study describing the efficacy and safety of DTG…

Long-term cohort

This is a long-term, post study cohort of HIV-infected patients who previously participated in HIV-NAT study…

A randomized double-blind phase II study comparing the efficacy, safety, and tolerability of combination antivirals (Amantadine, Ribavirin, Oseltamivir) versus Oseltamivir for the treatment of influenza in adults at risk for complications

This is a multicentered, randomized double-blind phase 2 study that will assess the efficacy, safety, and…

Towards a functional cure for HBV: exploiting lessons from HIV-HBV co-infection

This study willtest the hypothesis that HBsAg & HBeAg seroconversion/loss in HIV-HBV co-infected individuals following antiviral…

Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for drug-sensitive Tuberculosis (TRUNCATE-TB)

This is a two-month regimens using novel combinations to augment treatment effectiveness for drug-sensitive tuberculosis (TB):…

Peripheral Arterial Diseases among perinatally HIV-infected Thai adolescents

To assess the prevalences and incidences of peripheral arterial diseases among perinatally HIV-infected Thai adolescents

A phase IIIb, randomized, open-label study of the antiviral activity and safety of Dolutegravir compared to Lopinavir/Ritonavir both administered with dual nucleoside reverse transcriptase inhibitor therapy in HIV-1 infected adult subjects with treatment failure on first line therapy

This study is conducted to demonstrate non-inferior antiviral activity at 48 weeks of a dolutegravir (DTG)…

A randomized double-blind study comparing standard treatment versus placebo for the treatment of influenza in low risk adults

This is a randomized blinded study that will evaluate whether the standard treatment modifies viral shedding…

Gut microbiome and NASH in HIV

Description: n/a